US2019048035A1PendingUtilityA1

Processes for preparing macrolides and ketolides and intermediates therefor

59
Assignee: CEMPRA PHARMACEUTICALS INCPriority: May 20, 2010Filed: Mar 6, 2018Published: Feb 14, 2019
Est. expiryMay 20, 2030(~3.8 yrs left)· nominal 20-yr term from priority
A61P 31/04C07H 17/08C07H 1/00A61K 31/70C07D 498/04
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention described herein pertains to processes for the preparation of macrolide antibacterial agents. In particular, the invention pertains to processes for preparing macrolides and ketolides from erythromycin A.

Claims

exact text as granted — not AI-modified
1 .- 41 . (canceled) 
     
     
         42 . A process for preparing a compound of formula (I) 
       
         
           
           
               
               
           
         
       
       or a salt thereof, wherein:
 R 10  is hydrogen or acyl, 
 X is H; and Y is OR 7 ; where R 7  is a monosaccharide or X and Y are taken together with the attached carbon to form carbonyl; 
 V is C(O), C(═NR 11 ), CH(NR 12 R 13 ), or N(R 14 )CH 2 ; where N(R 14 ) is attached to the C-10 carbon; where R 11  is hydroxy or alkoxy; R 12  and R 13  are each independently selected from the group consisting of hydrogen, hydroxy, alkyl, alkoxy, heteroalkyl, aryl, arylalkyl, heteroaryl, and heteroarylalkyl, each of which is optionally substituted, and dimethylaminoalkyl, acyl, sulfonyl, ureido, and carbamoyl; R 14  is hydrogen, hydroxy, alkyl, alkoxy, heteroalkyl, aryl, arylalkyl, heteroaryl, or heteroarylalkyl, each of which is optionally substituted, or dimethylaminoalkyl, acyl, sulfonyl, ureido, or carbamoyl; 
 W is H, F, Cl, Br, I, or OH; 
 Z is an alkyne, an azide, or a C-substituted 1,2,3-triazole; 
 A is CH 2 , C(O), C(O)O, C(O)NH, S(O) 2 , S(O) 2 NH, or C(O)NHS(O) 2 ; 
 B is (CH2) n  where n is an integer from 0 to 10; or an unsaturated carbon chain of 2 to 10 carbons; and 
 C is hydrogen, hydroxy, alkyl, alkoxy, heteroalkyl, aryl, arylalkyl, heteroaryl, or heteroarylalkyl, each of which is optionally substituted, or acyl, acyloxy, sulfonyl, ureido, or carbamoyl; 
 the process comprising the step (a) contacting a compound of formula (III), 
 
       
         
           
           
               
               
           
         
       
       or a salt thereof, wherein Q in combination with the oxime oxygen forms an acetal or ketal, or Q is tropyl, with an acylating agent to form a compound of formula (IV) 
       
         
           
           
               
               
           
         
       
       or a salt thereof, wherein R is an acyl group;
 (b) contacting a compound of formula (IV), or a salt thereof, with a methylating agent, to form a compound of formula (V) 
 
       
         
           
           
               
               
           
         
       
       or a salt thereof;
 (c) optionally contacting a compound of formula (V), or a salt thereof, with a deoximating agent to form a compound of formula (II) 
 
       
         
           
           
               
               
           
         
       
       or a salt thereof; and 
       (d) contacting a compound of formula (V) or (II) with an activating agent and adding H 2 N-A-B-Z to prepare
 the compound of formula (I). 
 
     
     
         43 .- 46 . (canceled) 
     
     
         47 . The process of  claim 42  further comprising (c) contacting a compound of formula (V), or a salt thereof, with a deoximating agent to form a compound of formula (II) or a salt thereof; and wherein V is C(O). 
     
     
         48 . The process of  claim 42  wherein the deoximating agent prises a reducing agent. 
     
     
         49 . The process of  claim 42  wherein the deoximating agent in (c) comprises formic acid and sodium metabisulfite. 
     
     
         50 . The process of  claim 42  wherein the acylating agent is an anhydride. 
     
     
         51 . The process of  claim 42  wherein the activating agent is carbonyldiimidazole. 
     
     
         52 . The process of  claim 42  wherein Q in combination with the oxime oxygen forms an acetal or ketal. 
     
     
         53 . The process of  claim 42  wherein Q is 2-methoxy-2-propyl, 1-methoxycyclohexyl or 1-isopropoxycyclohexyl. 
     
     
         54 . The process of  claim 42  wherein R is an optionally substituted benzoyl group. 
     
     
         55 . The process of  claim 42  wherein R is benzoyl. 
     
     
         56 . The process of  claim 42  wherein R 10  is hydrogen. 
     
     
         57 . The process of  claim 42  wherein X is H, Y is OR 7 , and R 7  is cladinosyl. 
     
     
         58 . The process of  claim 42  wherein X and Y are taken together with the attached carbon to form carbonyl; and W is H or F. 
     
     
         59 . The process of  claim 42  wherein A is CH 2 ; and B is (CH 2 ) n . 
     
     
         60 . The process of  claim 42  wherein Z is an azide. 
     
     
         61 . The process of  claim 42  wherein Z is a C-substituted 1,2,3-triazole. 
     
     
         62 . The process of  claim 42  wherein C is optionally substituted aryl or optionally substituted arylalkyl. 
     
     
         63 . The process of  claim 42  wherein C is aminophenyl. 
     
     
         64 . The process of  claim 42  wherein the compound of formula (I) is solithromycin or a salt thereof.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.